From Silos to Synergy

摘要

Like many other industries, life sciences faces rapid, technology-driven changes and a shifting business environment. Manypatients are covered by Medicare, Medicaid, or national healthcare organizations outside the United States. That necessitates pricing and reimbursement negotiations that are complicated by rules and regulations. Patients whose health plans belong under amanaged-care organization (MCO) or pharmacy-benefit manager (PBM) have access to prescriptions primarily through staff-model pharmacies, mail-order pharmacies, and network pharmacies. Drug manufacturers offer incentives to such organizations in the formof rebates based on the formulary position of a given medication on a health plan.